ICML 2017 Highlights
BGB-3111 and ibrutinib for Waldenström’s macroglobulinemia
Results of Phase II trial to assess the efficacy and safety of idelalisib
What is the best conditioning regimen for children
What can clonal evolution in chronic lymphocytic leukemia (CLL) tell us about outcomes?